Lot numbers can be found on the outside label of a product:
Please log in for operation!
*For research and further manufacturing use only, not for direct human use.
Structure of 183322-18-1
| Size |
|
Price | Quantity | |||
|---|---|---|---|---|---|---|
|
* Please select Quantity before adding items. |
||||||
Synthesizing EGFR inhibitors like erlotinib, CP-335963 (CAS 183322-18-1) serves as a key quinazoline scaffold for dual-targeted kinase and epigenetic modulator development, enabling antiproliferative effects in oncogenic signaling pathways.
CP-335963 (CAS 183322-18-1) drives pharmaceutical development by serving as a critical intermediate in synthesizing targeted cancer therapeutics. It enables precise modulation of kinase pathways. Researchers leverage this scaffold to probe enzyme inhibition mechanisms and receptor binding dynamics. Its structural versatility supports agrochemical innovation, enhancing crop resilience. In material science, it fine-tunes polymer performance under extreme conditions. This compound also shows promise in diagnostic imaging agents.
|
GHS Pictogram :
|
GHS No : GHS05,GHS07
|
|
Signal Word : Danger
|
UN#: N/A
|
|
Class : N/A
|
Packing Group : N/A
|
|
Hazard Statements : H302-H318
|
|
|
Precautionary Statements : P264-P270-P280-P330-P501
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Upload Pictures
|
|
Lot numbers can be found on the outside label of a product: